Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Sirolimus in Solid Organ Transplant Recipients
NCT00037531Phase 3Completed
- Sponsor
- Pfizer
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of sirolimus in solid organ transplant rejection (SOTR), graft-versus-host disease (GVHD), sponsored by Pfizer. Status: completed.
02
Drugs
sirolimus
03
Conditions
solid organ transplant rejection (SOTR)graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00037531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037531.